KALA BIO, INC. Fair Value, Assets, Level 2 to Level 1 Transfers, Amount
KALA BIO, INC. (KALA) had Fair Value, Assets, Level 2 to Level 1 Transfers, Amount of $0 as of 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount · last filed 2022-05-16
- 2022-03-31: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2021-12-31: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2021-09-30: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2021-06-30: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
| Period end | Fair Value, Assets, Level 2 to Level 1 Transfers, Amount |
|---|---|
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 |
| 2021-12-31 | $0.00 10-Q · filed 2022-05-16 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-15 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-05 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-05 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-29 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-06 |
| 2019-12-31 | $0.00 10-K · filed 2020-02-12 |
| 2018-12-31 | $0.00 10-K · filed 2020-02-12 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-08 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-09 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-10 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-12 |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-08 |
| 2017-06-30 | $0.00 10-Q · filed 2018-08-09 |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |